Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001725663-26-000005

Chief Financial Officer sold 2,500 shares at $12.95 ($32,375)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

WENTWORTH KORY JAMES · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-01 Sale : show line 1 in the form 10b5-1 −2,500 $12.95 $32,375 119,010 D
Open-market sales · 2,500 sh · avg $12.95 · $32,375
Loading xslF345X06/wk-form4_1775162353.xml…